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Abstract
The mechanisms of liver injury associated with chronic HCV infection, as well as the individual roles of both viral and host
factors, are not clearly defined. However, it is becoming increasingly clear that direct cytopathic effects, in addition to
immune-mediated processes, play an important role in liver injury. Gene expression profiling during multiple time-points of
acute HCV infection of cultured Huh-7.5 cells was performed to gain insight into the cellular mechanism of HCV-associated
cytopathic effect. Maximal induction of cell-death–related genes and appearance of activated caspase-3 in HCV-infected
cells coincided with peak viral replication, suggesting a link between viral load and apoptosis. Gene ontology analysis
revealed that many of the cell-death genes function to induce apoptosis in response to cell cycle arrest. Labeling of dividing
cells in culture followed by flow cytometry also demonstrated the presence of significantly fewer cells in S-phase in HCV-
infected relative to mock cultures, suggesting HCV infection is associated with delayed cell cycle progression. Regulation of
numerous genes involved in anti-oxidative stress response and TGF-b1 signaling suggest these as possible causes of
delayed cell cycle progression. Significantly, a subset of cell-death genes regulated during in vitro HCV infection was
similarly regulated specifically in liver tissue from a cohort of HCV-infected liver transplant patients with rapidly progressive
fibrosis. Collectively, these data suggest that HCV mediates direct cytopathic effects through deregulation of the cell cycle
and that this process may contribute to liver disease progression. This in vitro system could be utilized to further define the
cellular mechanism of this perturbation.
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Introduction
Hepatitis C virus (HCV), a member of the Flaviviridae family, is a
blood-borne pathogen which currently infects approximately 170
million people worldwide. Exposure to HCV typically results in a
persistent infection and approximately 30% of chronically infected
patients will develop progressive liver disease including fibrosis,
cirrhosis and hepatocellular carcinoma (HCC) [1]. The majority of
pathology associated with chronic infection is believed to occur via a
HCV-specific cell-mediated immune response [2]. However, in light
of this, it is somewhat perplexing that liver disease progression is
accelerated in immuno-compromised individuals. Specifically,
HCV/HIV-coinfected patients and liver transplant patients receiv-
ing immuno-suppressive drugs tend to develop fibrosis/cirrhosis at a
much faster rate than immuno-competent individuals [3]. A recent
study found that HCV-specific CD8 T cells were actually associated
with areas of low hepatocellular apoptosis and weak fibrosis. It is
thought that these cells are protective of liver damage through
production of IL-10 [4]. Furthermore, characterization of the host
response to HCV infection in the SCID-Alb/uPA mouse model
demonstrated histological evidence of hepatocyte apoptosis in a
manner similar to that observed during acute HCV infection in
patients [5]. HCV infection in this model was associated with
perturbations in cellular pathways, including lipid metabolism and
oxidative stress, which have the potential to be cytopathic. The
inability of these animals to generate a virus-specific immune
response raises the intriguing possibility that HCV replication is
capable of directly mediating hepatocyte apoptosis.
It is now thought that both direct cytopathic effects and immune-
mediated processes likely play a role in HCV-associated liver injury
[3]. The cellular mechanisms by which HCV replication, and
subsequent virus-host interactions, may mediate liver injury are
unclear. Progress in this area has been hindered by the lack of
appropriate model systems in which to investigate the role of viral
factors in liver disease progression. Currently, studies focused on
defining the mechanisms of HCV-associated liver injury are
primarily restricted to limited analysis of patient samples, including
liver biopsy tissue. While such studies have provided significant
PLoS Pathogens | www.plospathogens.org 1 January 2009 | Volume 5 | Issue 1 | e1000269insight into the role of steatosis, oxidative stress and death-receptor
signaling inliver disease, there are obvious limitations with respect to
conducting more mechanistic studies, in particular the role of viral
proteins.
There is a wealth of literature describing experiments in which
one more HCV proteins are over expressed in cultured hepatocytes.
The results indicate a wide range of, and often conflicting, effects of
viral protein expression on cellular functions, including apoptosis
(Reviewed in Fischer et al, 2007). Core protein, in particular, has
been reported to have both pro- and anti-apoptotic effects on death-
ligand mediated hepatocyte apoptosis, including TNF-a, CD95Li-
gand and TRAIL-induced apoptosis, via a variety of mechanisms.
The HCV envelope protein E2 has been found to both inhibit
TRAIL-induced apoptosis and also to induce mitochondria-related/
caspase-dependent apoptosis in the same hepatoma cell line.
Perturbations of apoptotic pathways have also been demonstrated
with the non-structural proteins. The NS3 protease inhibits pro-
apoptotic RIG-I signaling via cleavage of the adaptor protein Cardif
and also induces apoptosis of hepatocytes via caspase-8. NS5A has
been found to inhibit apoptosis through multiple mechanisms,
including sequestering of p53, activation of NFkB, increased
expression of bcl-XL and p21 as well as activation of the P13-
kinase-AKt/PKB survival pathway. While intriguing, many of these
studies involve the expression of a single HCV protein, often at very
high levels which do not accurately represent those seen in naturally
infected livers. These experiments also fail to study the impact of
potentially crucial interactions between the different HCV proteins.
A significant breakthrough in HCV research was achieved by
the discovery of a specific HCV strain that efficiently infects and
replicates in the cultured hepatoma cell line Huh-7.5 [6,7,8,9].
This strain, termed JFH-1, was isolated from a Japanese patient
who suffered fulminant hepatitis following exposure to the virus
[6,7]. Subsequent inoculation of clonal JFH-1 into chimpanzees
and SCID-Alb/uPA mice resulted in productive infections in the
absence of fulminant hepatitis, suggesting that the host response to
infection played a key role in the severe form of hepatitis observed
in this patient [8]. This model system provides the opportunity to
study the impact of viral protein expression and replication on host
cell function during a productive HCV infection and to potentially
investigate the role of viral factors in liver injury. In the current
study, microarray experiments were performed to characterize the
host transcriptional response to HCV infection in an attempt to
gain insight into the mechanism of HCV-associated cell death.
Both the presence of activated caspase-3 and induction of cell
death-related genes indicated that HCV infection was associated
with a direct cytopathic effect. Gene ontology analysis suggests a
role of cell cycle perturbation, possibly in response to oxidative
stress and/or TGF-b1 signaling, in HCV-mediated apoptosis.
Results
HCV-J6/JFH Infection of Huh-7.5 Cells
To study the host response to infection during the early phase of
acute infection, Huh-7.5 cells were infected at a relatively high MOI
(1–2 virions/cell) with HCV genotype 2a chimeric virus, J6/JFH
(HCVcc) [7]. The virus used to infect cells was a pool of cell culture
adapted virions generated by multiple passages over naı ¨ve Huh 7.5
cells (see Materials and Methods). For infection controls, cells were
inoculated with either UV-inactivated HCVcc (to distinguish effects
due to virus binding and virus replication) or conditioned media
(mock). Conditioned media was used for the mock as it has been
shown that factors present in the media of cultured cells can induce
transcriptional changes (Walters, unpublished data). Cells were
incubated with HCVcc for approximately 8 hrs, after whichthe cells
were washed and fresh media added. Following infection, HCV (+)
cells were visualized using an anti-NS5A antibody. As shown in
Figure 1A, the majority of the cells expressed viral antigen by 48 hrs
post-infection and continue to do so for the remainder of the study.
No HCV RNA or viral protein expression was detected in cells
exposed to UV-inactivated HCVcc (data not shown). Samples were
harvested at 24, 48, 72,96, and 120 hourspost-infection andcellular
RNA isolated for measuring intracellular HCV RNA levels and for
global gene expression profiling.
Acute HCV Infection Induces Apoptosis of Cultured
Hepatoma Cells
Similar to what has been reported previously, a cytopathic effect
was observed in the cultures of cells infected with HCVcc starting
around 72 hrs post-infection (Figure 1B). This effect was not
observed in the cells exposed to either UV-inactivated HCVcc or
conditioned media, indicating that it is induced by active viral
replication. The cytopathic effect became more prominent at
96 hrs and appeared to include the majority of the cells by 120 hrs
post-infection (Figure 1B). Immuno-histochemistry specific for
cleaved caspase-3 demonstrated activation of a terminal pathway
involved in apoptosis that appears to cause the cytopathic effect in
culture. As shown in Figure 1C, cleaved caspase-3 was present in
cells infected with HCVcc beginning around 72 hrs, suggesting
that the mechanism of cell death was apoptosis. It was not
observed in cells exposed to either conditioned media (data not
shown) or UV-inactivated virus. The initial presence of activated
caspase-3 also coincided with peak levels of intracellular viral RNA
(Figure 2B), suggesting a causative link between the level of HCV
replication and cell death.
Global Transcriptional Response to Acute HCV Infection
of Cultured Hepatoma Cells
Microarray experiments were performed to characterize the
host transcriptional response to HCV infection in an attempt to
gain insight into the mechanism of HCV-associated cell death. For
these experiments, mRNA samples isolated from cells exposed to
either HCVcc or UV-inactivated HCVcc were compared to
Author Summary
Chronic HCV infection is associated with progressive liver
injury and subsequent development of fibrosis/cirrhosis.
The cellular mechanisms by which HCV replication, and
subsequent virus–host interactions, may mediate liver
injury are unclear. Microarray experiments were performed
to characterize the host transcriptional response to HCV
infection of cultured hepatocytes in an attempt to gain
insight into the mechanism of HCV-associated cell death.
Analysis of the gene expression data revealed that many
differentially regulated genes function to induce apoptosis
in response to cell cycle arrest, possibly in response to DNA
damage and oxidative stress. Labeling of dividing cells in
culture followed by flow cytometry also demonstrated the
presence of significantly fewer cells in S-phase in HCV-
infected cultures relative to mock cultures, suggesting HCV
infection is associated with delayed cell cycle progression.
Finally, many of the cell-death–related genes whose
expression changes in response to HCV infection of
cultured hepatocytes were also differentially regulated in
liver tissue from HCV-infected patients with histological
evidence of fibrosis. In summary, HCV may mediate direct
cytopathic effects through perturbation of the cell cycle
which potentially contributes to liver disease progression.
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shows the global gene expression profiles of cells infected with UV-
inactivated HCVcc and HCVcc at 24, 48, 72, 96, and 120 hrs
post-infection. Similar to what was observed in previous genomic
studies using the chimpanzee and SCID-Alb-uPA mouse models,
the overall effect of HCV infection on cellular gene expression was
subtle in the early phases of infection, with less than 50
differentially regulated genes at 24 hrs post-infection. Overall,
860 genes showed a 2-fold or higher change in expression (P
value#0.05) in at least one experiment (Figure 2A). The primary
sequence name and fold-change of these genes are shown in Table
S1. In contrast, cells exposed to the UV-inactivated virus showed
very little, if any, regulation of genes (2-fold change, P value#0.05)
throughout the time-course, indicating that the process of virus
attachment and entry into cells does not significantly impact host
cell gene expression. A similar lack of differential regulation was
Figure 1. Characterization of HCV-JFH infection of Huh-7.5 cells. (A) Expression of HCV NS5A in Huh-7.5 cells. HCV (+) cells are detected using
an anti-NS5A antibody (green) while all cell nuclei are shown using Hoechst dye (blue). (B) Cytopathic effect observed during later time-points of HCV
infection in Huh-7.5 cells. (C) Presence of activated caspase-3 (red) as shown by immuno-fluorescence staining of HCV-infected Huh-7.5 cells. Nuclei
are shown using Hoechst dye (blue).
doi:10.1371/journal.ppat.1000269.g001
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HCV full-length replicon (data not shown). As shown in Figure 2B,
there was a clear association between intracellular HCV RNA levels
and number of differentially expressed genes, with the maximum
regulation of cellular genes coinciding with peak intracellular HCV
RNA levels (72 hrs post-infection). The reason for the decreasing
HCV RNA levels following 72 hrs is unclear but may be related to a
decrease in the number of cells capable of producing high levels of
virus. It is interesting to note that the majority of transcriptional
changesinvolveincreasedexpression ofhostgenes.Few differentially
expressed genes showed decreased expression in the HCV-infected
relative to the mock-infected cultures (Figure 2A), although the
significance of this finding is unclear.
Potential Role of Cell Cycle Perturbation in HCV-Mediated
Apoptosis of Huh-7.5 Cells
Gene ontology analysis was used to identify the cellular
processes represented by the changes in steady-state abundance
of transcripts associated with HCV infection. Notably, many of the
differentially expressed genes belong to functional categories of cell
death, cell cycle and cell growth/proliferation. Indeed, cell death
genes comprised approximately half of all annotated differentially
regulated genes at each time-point, with the exception of 24 hrs
post-infection which showed negligible regulation of cellular genes.
Figure S1 demonstrates the expression profiles of 118 genes
associated with cell death in HCV-infected cells. Differential
expression occurred beginning at 48 hrs post-infection at which
time there was no significant visual evidence of cytopathic effect or
apoptosis. Maximum differential expression of cell death genes
occurred at 72 hrs post-infection whereas the level of apoptosis, as
measured by caspase-3 cleavage, continued to increase until
120 hrs post-infection.
Both the differential expression of cell death-related genes and
detection of cleaved caspase-3 in HCV-infected cells indicated that
the observed cytopathic effect is apoptosis. Ingenuity Pathway
Analysis identified a large number of cell death-related genes that
function in cell cycle checkpoint/arrest, suggesting a potential role
of cell cycle perturbation in apoptosis of infected cells (Figure 3).
Consistent with this, a significant number of genes were identified
that are associated with the DNA damage/oxidative stress
response, many of which belong to the NRF2-mediated oxidative
stress response pathway. This suggests that HCV replication is
associated with generation of reactive oxygen species (ROS).
Interestingly, the expression of two members of this pathway (CAT
and EPHX1) was decreased, suggesting the ability of the cells to
deal with excess ROS may be impaired. Apoptosis associated with
cell cycle arrest is thought to be mediated through the
mitochondria and p53 pathway [10]. In support of this, there
was regulation of genes that have been linked to cytochrome c
release from mitochondria (BBC3, BIK, BMF, PMAIP1, GSN,
HRK). Many of these genes, along with others (DAPK3, CASP4,
RIPK2), are also known to specifically regulate caspase activation.
Interestingly, Ingenuity Pathway Analysis revealed that p53
signaling was significantly effected during HCV infection and this
could provide the important link between oxidative stress/DNA
damage, cell cycle arrest and apoptosis. Indeed, many of the
Figure 2. Host transcriptional response to acute HCV infection of Huh-7.5 cells. (A) Expression profiles of 860 sequences that are regulated
(2-fold, P value,0.05) in at least 1 experiment. Each column represents gene expression data from an individual experiment comparing either UV-
inactivated HCVcc or HCVcc-treated cells relative to time-matched, mock-treated Huh-7.5 cells. Genes shown in red were up-regulated, genes shown
in green down-regulated, and genes in black indicate no change in expression in HCV-infected cells relative to uninfected cells. (B) Association
between intracellular HCV RNA levels and effect on host gene expression in HCV-infected Huh-7.5 cells. Intracellular HCV RNA levels were determined
by quantitative RT-PCR as described in Materials and Methods. Total number of genes showing differential regulation (2-fold, P value,0.05) in HCV-
infected cells relative to uninfected cells is shown in black line while the HCV viral load are shown using grey bars. Cells exposed to UV-inactivated
HCVcc show negligible virus and gene expression changes and so are not shown.
doi:10.1371/journal.ppat.1000269.g002
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are involved in cell cycle arrest (TP53INP1, GADD45A,
GADD45B, KLF6, UHRF1) and DNA damage/oxidative stress
response (PMAIP1, ATF3, BBC3, FOXO3A, NOXA, CAT,
UHRF1) regulate apoptosis via interaction with p53.
HCV Infection Is Associated with Delayed Cell Cycle
Progression
The functional categories cell cycle and cell growth/proliferation
were also significantly enriched among genes showing differential
expression during HCV infection. However, the majority of the
differentially expressed genes associated with cell cycle regulation
were involved with cell cycle checkpoint/arrest and subsequent
induction of apoptosis, rather than actual progression through the
cell cycle (Figure 4A). This likely explains the significant overlap
between cell cycle genes and those associated with cell death as
described above. Many of the genes associated with checkpoint/
arrest involved the G1/S phase transition, suggesting that this
checkpoint is the main area of cell cycle regulation by HCV
replication. Similar to what was observed with apoptosis-associated
genes,manycellcycle genes function to inducecellarrestinresponse
to DNA damage and cellular stress. Genes previously identified as
transcriptional targets of p53-induced growth arrest and apoptosis
(BBC3, PMAIP1, AURKB, MKi67, RRM2, MCM4, and MCM6)
were also differentially regulated in HCV-infected cells. Again this
suggests that perturbations in the p53 signaling pathway play a key
role in perturbation of cell cycle and induction of apoptosis during
HCV infection [11,12]. Increased expression of genes encoding
proteins which function to either decrease p53 levels or serve as a
protective effect against p53-dependent apoptosis (TYMS, JUND,
and UBD) suggests the cell is attempting to counteract the activation
of the p53 signaling pathway. Alternatively, the cell may be trying to
undergo apoptosisand the virus istrying to counteracttheprocess. A
much smaller set of genes associated with mitosis and cell cycle
progression (positive regulators of cell proliferation) were also
differentially regulated. Interestingly, the expression of MK167,
Mcm4 and Mcm6, common markers of cell proliferation, are
decreased during HCV infection. This is consistent with the
observation that proliferation of HCV-infected Huh-7.5 cells was
slower than naı ¨ve cells and provides further support that HCV-
infection delays cell cycle progression (data not shown). Quantitative
PCR analysis of a number of the genes shown in Figure 4A
Figure 3. Gene ontology analysis and expression of a subset of cell-death–related genes regulated during HCV infection. Gene
annotation was performed using Ingenuity Pathway Analysis and Entrez gene. Heatmap shows expression profiles of sequences that are regulated (2-
fold, P value,0.05) in at least 1 experiment. Each column represents gene expression data from an individual experiment comparing either UV-
inactivated HCVcc or HCVcc-treated cells relative to time-matched, mock-treated Huh-7.5 cells. Genes shown in red were up-regulated, genes shown
in green down-regulated, and genes in black indicate no change in expression in HCVcc-infected cells relative to uninfected cells.
doi:10.1371/journal.ppat.1000269.g003
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the microarrays (Figure 4B), although the ratios calculated from RT-
PCR generally exceeded those obtained using microarrays.
Flow cytometry analysis was performed to determine if HCV
infection was associated with alterations in the cell cycle.
Specifically, the number of cells progressing through S-phase of
the cell cycle was determined by pulse-labeling the cells with the
nucleoside EdU (5-ethynyl-29-deoxyuridine), followed by a copper-
catalyzed covalent reaction to fluorescently detect the DNA-
incorporated nucleoside analog (see Materials and Methods). At
72-hours post-infection, approximately 21% of the HCV-infected
population showed evidence of EdU incorporation/DNA synthe-
Figure 4. Cell cycle analysis during HCV infection. (A) Gene annotation was performed using Ingenuity Pathway Analysis and Entrez gene.
Expression profiles of sequences that are regulated (2-fold, P value,0.05) in at least 1 experiment. Each column represents gene expression data from
an individual experiment comparing either UV-inactivated HCV or HCV-treated cells relative to time-matched, mock-treated Huh-7.5 cells. Genes
shown in red were up-regulated, genes shown in green down-regulated, and genes in black indicate no change in expression in HCV-infected cells
relative to uninfected cells. (B) RT-PCR validation of the expression array data. Data are shown as log10 ratio and reflect the difference in expression
between HCV-infected (72 hours post-infection) and mock Huh-7.5 cells. (C,D) Analysis of proliferating cells at 72 hours post-infection with HCV or
UV-inactivated virus (UV-HCV). Following a 3-hour pulse with the nucleoside analog EdU, cells were enumerated by flow cytometry (C) or visualized as
adherent cells using immunofluorescence (D).
doi:10.1371/journal.ppat.1000269.g004
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(Figure 4C). This significant reduction of labeled cells in the
HCV-infected population suggests reduced cellular proliferation,
or a block in cell cycle progression prior to S-phase, due to the
presence of the virus. Comparable results were obtained when
performing the analysis by immuno-fluorescence on fixed/
attached cells (Figure 4D). Reduced cell proliferation due to
HCV could also be seen at earlier time-points (24 and 48 hours
post-infection), but the difference was not as dramatic, although it
was progressive (data not shown).
Cytokines Induced during Acute In Vitro HCV Infection
Are Associated with Disease Progression in Patients
HCV infection was also associated with differential expression of
genes associated with cytokine/growth factor signaling, with the
highest induction again at 72 hours post-infection (Figure 5). These
genes included pro-inflammatory cytokines which are chemotactic
for specific immune cells (e.g. CCL4-macrophages, CXCL1-
neutrophils, IL8/CXCL2/CXCL3-PMNs, CX3CL1-macrophages,
NK, lymphocytes, and CCL20-dendritic/lymphocytes). Of partic-
ular interest, some of the cytokines induced by HCV infection in vitro
(including CCL4, CXCL1, IL32, TGFbI, TNFRSF12A, SOCS3
and TNFSF14) were identified by ANOVA analysis as being
significantly (P value,0.01) associated with fibrosis progression in
these transplant patients (data not shown). The fact that they are
induced in HCV-infected Huh-7.5 cells suggests that hepatocytes
themselves are an important source of these cytokines in an HCV-
infected liver. The induction of SOCS2 and SOCS3, negative
regulators of cytokine signaling, may indicate that the hepatocytes
are actually trying to attenuate the expression of cytokines, possibly
because they are negatively impacting cell viability. Interestingly,
despite the lack of both TLR3 and a functional RIG-I in Huh-7.5
cells, induction of known interferon stimulated genes (ISGs),
including ISG15 and ISG20, was also observed. Comparison of
the gene expression profiles of HCV-infected and IFN-treated Huh-
7.5 cells revealed significant overlap in differentially regulated genes,
suggesting thatHCV infection isassociated with activation ofType 1
IFN signaling (data not shown). As the cultures were nearly 100%
infected, the expression of these genes is likely coming from HCV-
infected hepatocytes.
TGF-b1 is the most likely candidate for exerting effects on
hepatocytes that are consistent with the gene expression data
indicating cell arrest and apoptosis. It is a potent inhibitor of cell
growth of many cell types, including hepatocytes, and growth arrest
occurs by blocking the cell cycle at middle and late G1 phase of cell
cycle [13]. Although TGF-b1 itself was not induced, there was
increasedabundanceofasignificantnumberofgenesassociatedwith
TGF-b1 signaling, particularly at 72 hrs post-infection. Many of
these genes are either associated with the TGF-b1 signaling pathway
(BMP2, TGIF1, SMAD7 and 9, MRAS, FOS, ROR1, PDGRFA,
JUN, INHBA) and/or are known to be regulated by TGF-b1. The
increased expression of Smad7, which provides a TGF-b1-induced
negative feedback loop by inhibiting nuclear translocation of SMAD
proteins, suggests that TGF-b1 is produced and interacting with
receptors present on hepatocytes [14]. Interestingly, KLF10 (also
known as TIEG) is a gene induced by TGF-b1t h a ti n d u c e st h e
generation of ROS and the loss of mitochondrial membrane
potential prior to death. This, together with the fact that p53 plays a
key role in TGF-b1-induced growth arrest [15], may provide an
important link between the three most significant pathways affected
by HCV replication: TGF-b1 signaling, p53 signaling and the
NFR2-mediated oxidative stress response (Figure 6). As indicated by
the network analysis, there is extensive interaction between genes
associated with these pathways.
Common Regulation of Cell-Death– and Cytokine-
Signaling–Related Genes during In Vitro Infection and
Recurrent HCV Infection in Liver Transplant Patients
As part of a separate study examining the progression of fibrosis
in liver transplant patients with re-current HCV, microarray
experiments were performed comparing individual patient liver
biopsy tissue (n=25) to a pool of normal, uninfected liver tissue.
To determine the clinical relevance of transcriptional changes
observed in HCV-infected Huh-7.5 cells, the expression of the cell
death-related genes regulated at 72 hrs post-infection was assessed
in liver tissue from these HCV-infected patients. As shown in
Figure 7A, many of the genes that were induced during HCV
infection in cell culture were also regulated during re-current
HCV infection in liver transplant patients. Interestingly, the
increased expression of a subset of these genes appeared to be
associated with liver disease progression as they were, in general,
more highly induced in patients who developed rapidly progressive
fibrosis post-transplant (indicated in red text) than in patients who
did not (black text). The fact that only a subset of the cell death
genes regulated in vitro were regulated in liver tissue can likely be
Figure 5. Expression profiles of cytokine/growth factor signal-
ing-related genes in HCV-infected Huh-7.5 cells. Heatmap
depicts 70 genes regulated (2-fold, p value,0.05) in at least 1
experiment. Each column represents gene expression data from an
individual experiment comparing either UV-inactivated HCV or HCV –
treated cells relative to time-matched mock-treated Huh-7.5 cells.
Genes shown in red were up-regulated, genes shown in green down-
regulated and genes in black indicate no change in expression in HCV-
infected cells relative to uninfected cells.
doi:10.1371/journal.ppat.1000269.g005
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and multiple cell types in the livers of chronically infected patients.
A similar scenario was observed when the expression of cytokine
signaling genes differentially regulated during HCV infection of
Huh-7.5 cells was assessed in the patient cohort. A subset of these
genes was more highly expressed in patients who develop recurrent
liver disease (indicated in red text in Figure 7B). Significantly, some
were identified by ANOVA (comparing patients with and without
re-current disease post-transplant) as being statistically (P val-
ue,0.05) associated with fibrosis development. Collectively, these
data demonstrate that, despite JFH-1 being somewhat of an atypical
HCV, transcriptional changes which occur in HCV-infected Huh-
7.5 cells parallel those which occur specifically during fibrosis
development in HCV-infected patients.
Discussion
This study represents the first report of global transcriptional
profiling of HCV-J6/JFH-infected cultured human hepatoma
cells. It is unique in that it examines the host response to in vitro
infection during the early acute phase of infection. The host
transcriptional response corresponds closely to the levels of HCV
replication, with the most gene expression changes coinciding with
peak intracellular viral load (72 hours). No changes in gene
expression were observed in cells treated with UV-inactivated
HCVcc, indicating that viral attachment/entry does not signifi-
cantly impact host gene expression. It also indicates that the
changes observed in the HCV-infected cells are dependent on
HCV replication and not the interaction of secreted cellular
Figure 6. Ingenuity network diagram depicting interactions between the components of the p53, TGF-b1, and NFR2-mediated
oxidative stress signaling pathways. Lines indicate known interactions between proteins (sold lines depicts direct and dashed lines depict
indirect interaction). Gene expression data from 72 hrs post-infection was overlaid onto the network with genes showing increased and decreased
expression (relative to mock) shown in red and green, respectively. For visualization, network was mainly restricted to genes showing regulation
during infection and not all interactions between genes from different pathways are indicated.
doi:10.1371/journal.ppat.1000269.g006
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dependent and -independent transcriptional changes are observed
during acute influenza virus infection [16]. This discrepancy may
be a reflection of inherent differences in host response to acute
versus chronic viruses. Chronic viruses such as HCV may have
evolved to cause minimal impact upon entry into cells in an effort
to delay cellular changes that may trigger an immune response, as
evidenced by the minimal effect on host gene expression even at
24 hrs post-HCV infection. Similar results were obtained in
transcriptional profiling of acute HBV infection in chimpanzees,
where viral entry and expansion occurred in the absence of host
gene regulation [17].
Significantly, the results of this study indicate that HCV has the
potential to mediate direct cytopathic effects, suggesting that not
all liver injury during chronic HCV infection is immune-mediated.
The initial appearance of cytopathic effect, activated caspase-3
and the highest induction of cell death-related genes all coincided
with peak viral loads, suggesting that intrahepatic HCV RNA
levels play a role in hepatocyte cell death. While the role of viral
load in HCV-liver disease remains controversial, there is evidence
to suggest that higher replication rates are associated with more
severe liver disease, particularly in the liver transplant setting.
Significantly higher pre- and post-transplant serum HCV levels
has been associated with cholestatic fibrosis, a severe form of
hepatitis [18]. Similarly, elevated serum HCV pre-transplant is
associated with accelerated HCV-induced allograft injury [19].
High levels of intrahepatic HCV in biopsies taken at early times
post-transplant was found to be an independent predictor of
progression to chronic active hepatitis [20]. In the non-transplant
setting, in situ hybridization demonstrated an association between
the number of hepatocytes harboring replicating HCV and
severity of fibrosis [21]. Collectively, these studies suggest that
elevated viral replication may cause increased liver injury.
Differences in viral load may actually provide an explanation for
the discrepancy in the level of hepatocyte cell death that occurred
in vitro, which involved the majority of cells, and during chronic
HCV infection. The lack of important dsRNA signaling molecules
in the hepatoma cell line Huh-7.5 used for this study allows higher
levels of HCV replication than what is typically observed in the
liver of chronic HCV patients (Walters, unpublished data),
presumably due to decreased activation of an intracellular innate
antiviral response. The balance of IFN-mediated suppression of
HCV replication and HCV-mediated regulation of host innate
antiviral pathways likely varies from cell to cell in infected livers. If
the balance shifts more toward HCV control over innate antiviral
signaling, then HCV levels within that cell may increase to a level
that is incompatible with cell survival. HCV infection in Huh-7.5
cells likely reflects the extreme of this situation. Indeed, levels of
Figure 7. Common regulation of cell-death– and cytokine-related genes HCV-infected cultured hepatocytes and patient liver tissue.
(A) Expression of cell-death–related genes in individual liver biopsies from HCV-infected liver transplant patients (n=25). Two-dimensional
hierarchical clustering was done using Resolver System software with an agglomerative algorithm, complete link heuristic criteria, and Euclidean
correlation metric. Each column represents gene expression data from an individual experiment comparing a single HCV-infected liver tissue to a
pool of normal, uninfected liver tissue. Heatmap depicts a subset of 96 genes from Figure S1 that are regulated (2-fold, p value,0.05) in at least 3
experiments. Patients with fibrosis are indicated in red text while non-fibrotic patients are shown in black text. (B) Expression of cytokine- related
genes in liver biopsy tissue from HCV-infected liver transplant patients. Heatmap depicts a subset of 50 genes from Figure 5 that are regulated (2-fold,
p value,0.05) in at least 3 experiments. Patients with fibrosis are indicated in red text while non-fibrotic patients are shown in black text.
doi:10.1371/journal.ppat.1000269.g007
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cells and is associated with a delay in cell death. It is possible that
apoptotic hepatocytes in infected livers also have higher levels of
HCV replication than non-apoptotic cells, although this would be
technically challenging to demonstrate.
A significant proportion of differentially expressed genes during
in vitro HCV infection were associated with cell cycle checkpoint/
arrest and subsequent induction of apoptosis, which may have
been in response to oxidative stress/DNA damage. Also, the
observed delayed growth kinetics of HCV-infected cells and flow
cytometry analysis demonstrating fewer cells in S-phase, suggests
that delayed cell cycle progression may be involved in HCV-
mediated cytotoxicity. This is particularly interesting in light of
recent studies where immuno-histochemistry of patient liver
biopsies demonstrated that few hepatocytes which have entered
the cell cycle go beyond G1 phase during chronic HCV infection
[22,23]. The G1 arrest observed in patient livers was associated
with increased expression of p21, a cdk-cyclin inhibitor which
causes G1 arrest after DNA damage. A correlation was observed
between p21 expression and fibrosis severity, suggesting a link
between delayed cell cycle progression and liver injury. Such
results suggest the delay in cell cycle progression observed in
HCV-infected Huh-7.5 cells is physiologically relevant. Consistent
with these in vivo studies, many of the genes associated with arrest
during in vitro HCV infection are involved in G1 arrest or
transition from G1 to S phase. Interestingly, a link between
perturbations in cell cycle control and pathogenesis has been
observed in SIV infection in non-human primates, another
chronic viral infection that can have different disease outcomes.
Perturbation of the cell cycle within CD4 (+) T lymphocytes is
characteristic of pathogenic HIV/SIV infection [24,25,26] and,
similar to what is proposed in the current study, increased T
lymphocyte susceptibility to apoptosis correlates with cell cycle
perturbation [26]. Unlike the AIDS field, there is no animal model
of HCV-associated liver disease in which to validate the biological
significance of events which occur in cell culture models. To
circumvent this challenge, gene expression data from in vitro HCV
infection was integrated with an extensive database of patient liver
microarray experiments. The intriguing finding that a higher
induction of a subset of these genes was observed in HCV-infected
patients with rapidly progressive fibrosis post-transplant, but not
those HCV-infected patients lacking histological evidence of
fibrosis, also suggests a potential role of cell cycle perturbations
in HCV pathogenesis. However, it is important to note that this
patient cohort is immuno-compromised and so it is uncertain if
HCV-associated CPE causes significant liver injury in immuno-
competent individuals.
Both gene expression profiling and flow cytometry analysis
suggest that HCV-mediated apoptosis of Huh-7.5 cells is linked to
perturbations in cell cycle progression. However, it is difficult to
determine from the gene expression data if the cell cycle arrest is
directly linked to apoptosis or if there other factors that are driving
the arrested cells to undergo apoptosis. It is also not clear what
factors are responsible for inducing the delay in cell cycle
progression. Perturbation of the cell cycle may be mediated
directly by HCV proteins, as has been observed in other viral
infections including HIV (vpr) and HBV (x protein) [27,28]. Due
to the association between chronic HCV infection and develop-
ment of hepatocellular carcinoma, there has been keen interest in
the impact of HCV on cell cycle regulation. Core protein in
particular has been implicated in impairment of G1 to S phase
transition through multiple mechanisms, including induction of
p21 expression and concomitant decrease in cdk2 activity [29],
direct interaction and suppression of CAK activity [30], and
stabilization of cell cycle inhibitor p27 [31]. Delayed progression
through S-phase has been shown to be mediated both by NS2-
mediated down-regulation of cyclin A [32] and NS5B induction of
IFN-B [33]. NS5A-induced chromosome instability has been linked
to aberrant mitotic regulation, including impaired mitotic exit [34].
It is unclear whether delaying cell cycle progression would be
beneficial or detrimental to HCV replication. The liver is normally a
quiescent organ and so hepatotropic viruses which establish chronic
infections, such as HBV and HCV, may have evolved to replicate
efficientlyundersuchnon-proliferatingconditions.Insupportofthis,
production of infectious HCV in cultured hepatoma cells does not
seem to be significantly impacted during growth arrest induced by
either serum starvation or DMSO [35,36].
The differential regulation of numerous genes associated with
DNA damage/oxidative stress response, including many associat-
ed with the NRF2-oxidative stress response, suggests this as a
possible mechanism of arrest. Oxidative stress has long been
thought to play a key role in HCV pathogenesis and a potential
link between HCV-associated perturbation of lipid metabolism
genes and oxidative stress was observed in the SCID-Alb/uPA
mouse model [5]. Specifically, HCV-infected animals showing
induction of genes functioning in cholesterol biosynthesis,
peroxisome proliferation, and b-oxidation also showed induction
of genes which function in antioxidant cell defense, presumably
due to generation of reactive oxygen species (ROS) during b-
oxidation of fatty acids. In the current study, oxidative stress
appears to be independent of lipid metabolism. No significant
regulation of genes associated with cholesterol synthesis or
enzymes involved in b-oxidation was observed at any time-point
of infection. It is possible that the presence of viral gene products or
replication directly results in the generation of ROS. Core protein
has been implicated in perturbations in mitochondrial function,
including release of cytochrome c and loss of membrane potential,
as well as production of ROS in a variety of systems [37,38,39].
Consistent with the current study, expression of full-length HCV
open reading frame was found to cause marked growth inhibition
and increased intracellular ROS [40]. Preliminary global quanti-
tative proteomic data showed multiple perturbations in the host
proteome indicative of HCV-associated metabolic stress and ROS
generation as early as 24 h post infection (Diamond et al,
manuscript in preparation). Consistent with this idea, these
perturbations were accompanied by a concomitant increase in
proteins functioning in antioxidant cell defense.
Another possible mechanism of cell arrest could be through
activation of TGF-b1 signaling. TGF-b1 is a potent inhibitor of
cell growth and apoptosis of many cell types, including
hepatocytes, and growth arrest occurs by blocking cell cycle at
mid and late G1 phase [13,14]. This is consistent with the gene
expression data showing regulation of numerous genes involved in
G1 arrest. Significant correlations between TGF-b1 polymor-
phisms, intensity of hepatocyte-specific TGF-b1 staining, serum
TGF-b1 levels and degree of fibrosis have consistently been
demonstrated in HCV-infected patients [41,42,43]. However, its
role in hepatocyte apoptosis during HCV infection remains
unclear. The possibility that TFG-b1 may be directly involved
in HCV-associated cell cycle arrest is intriguing. While increased
expression of TGF-b1 was not observed in the current study, the
expression of numerous genes associated with TGF-b1 signaling
pathway, and those known to be induced by TGF-b1, was elevated
during infection. It is possible that very low levels of the cytokine
are needed to activate the pathway, a scenario similar to what is
observed with Type 1 IFN and ISGs. Furthermore, in an infected
liver other cell types, including hepatic stellate cells, are an
important source of TGF-b1. Chronic HCV infection is
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usually in the absence of detectable increased expression of IFN-
a/b [5,44]. TGF-b1 has been proposed as a potential therapeutic
target for treatment of viral hepatitis and so a clear understanding
of the role it plays in HCV pathogenesis is crucial [45]. Further
study is warranted to determine if TGF-b1 is inducing cell arrest
and also whether this is directly linked to apoptosis or simply
sensitizing cells to apoptosis through alternative mechanisms,
including the effects of oxidative stress.
Alternate mechanisms of HCV-induced cytopathic effects, such
as through induction of ER stress, have been proposed [46].
However, there was little evidence for regulation of genes
associated with either ER stress or the unfolded protein response
in the current study. This is consistent with a recent study
demonstrating that HCV-JFH-1 mediates apoptosis through a
mitochondrion-mediated, caspase-3 dependent pathway in the
absence of ER stress [47]. Although ER stress is associated with
transcriptional regulation of a subset of genes, it is unclear if gene
expression profiling would accurately detect ER stress and so it
should not be ruled out as a possible contributor of apoptosis in the
current study. Apoptosis has also been found to be mediated
through the induction of the death ligand, TRAIL, and its
receptors [48]. No increase in the expression of TRAIL, or its
receptors, was observed in the current study, making it unlikely to
be involved in apoptosis of Huh-7.5 cells. This is possibly related to
the absence of functional RIG-I and TLR3 in these cells, which
are key components of dsRNA signaling pathways. It is important
to note that these alternative mechanisms of HCV-mediated cell
death are not necessarily mutually exclusive, and multiple
mechanisms of cytotoxicity may be involved in liver injury during
chronic HCV infection.
Collectively, the gene expression data and flow cytometry
analysis suggests that HCV infection is associated with perturba-
tion of the cell cycle which may sensitize cells to apoptosis.
Significantly, the integration of the in vitro and patient liver gene
expression data also suggests that this process contributes to liver
disease progression. These results suggest that despite the fact that
HCV typically establishes persistent infections, events which occur
during the very acute phase of infection of individual hepatocytes
can determine the ultimate fate of the cell. During the time this
manuscript was in preparation, a report was published describing
altered expression of cell cycle and apoptotic proteins, as
demonstrated using immunohistochemistry, in liver biopsies from
chronic HCV patients [49]. However, the delay in cell cycle
progression and apoptosis were observed in separate cell types
(hepatocytes versus sinusoidal cells, respectively). The results of the
current study demonstrate that cell cycle perturbation and
apoptosis occur in the same cell, suggesting a direct link, and
also provide additional insight into potential mechanisms of cell
cycle perturbation, including oxidative stress and TGF-b1
signaling. Further study is warranted to more clearly define the
mechanism of HCV-associated cell cycle perturbation. This may
provide significant insight into the pathogenesis of HCV infection
with the possibility of identifying novel therapeutic targets.
Materials and Methods
Generation of HCVcc Stocks and Experimental Infections
Huh 7.5 cells (human hepatoma) were electroporated with 1 mg
of in vitro transcribed RNA from the chimeric HCV genome J6/
JFH (see reference 7); five identical electroporations were
performed. Cells were expanded three times following electropo-
ration and supernatants were pooled and used to infect naı ¨ve Huh
7.5 cells. Following a single expansion of infected cells, virus
containing supernatants were collected, pooled, and used to again
infect naı ¨ve Huh 7.5 cells. This process was repeated a total of five
times and resulted in the generation of a relatively high titer
(2610
5 TCID50/ml) and large volume (,500 mls) of stock virus
(HCVcc). Approximately one-half of the HCVcc stock was
exposed to UV light for 60 seconds, using a Stratalinker UV light
box, and served as a non-infectious control (UV-HCV). In
addition, during the multiple passages of HCVcc on naı ¨ve cells,
a mock control sample was generated by passing conditioned
media along in parallel. For infections, Huh 7.5 cells were seeded
at a density of 3610
6 cells/plate on p150 plates and treated for
,8 hours with 20 mls of supernatant containing virus (HCVcc),
UV-inactivated virus (UV-HCV), or conditioned media (mock).
This amounted to a moi of ,1.3. Following initial infection, the
supernatant was replaced with fresh media and incubated until
harvest at 24, 48, 72, 96, and 120 hours post-infection.
Isolation of Total Cellular RNA
Following removal of supernatant, cells were washed once with
PBS and then scraped from the plate in ice cold PBS. RNA was
isolated from approximately 10
6 cells using RNeasy mini prep kit
with an on-column DNase treatment, following the manufacturer
protocol (Qiagen).
Immuno-Fluorescence Staining
Cells were fixed in 220uC methanol or 1% paraformaldehyde (in
PBS at room temperature) for 15–20 minutes. Following a series of
PBS rinses, the cells were blocked in 1% BSA/0.2% skim milk in
PBS for 30–60 minutes at room temperature. Cells were incubated
in primary antibody (diluted in 0.5% Tween-20 in PBS) overnight at
4uC;mouse anti-NS5A (1:2000,Clone9E10,ref.21)and rabbitanti-
activated caspase-3 (1:500, Cell Signaling). Click-iT EdU chemistry
was performed following manufacturer protocol (Invitrogen); 10 mM
EdU labeling for 3 hours and 30 minute reaction with AlexaFluor
488 azide (1:400 dilution). Secondary antibodies are AlexaFluor
conjugated and used at 1:1000 dilution; goat anti-mouse Alexa-
Fluor488 and goat anti-rabbit AlexaFluor594.
Flow Cytometry Analysis
Cells were trypsinized, washed twice with ice cold PBS and fixed
1% paraformaldehyde for 20 minutes. Following a series of PBS
rinses, the cells were blocked and permeabilized in 0.1% FBS/
0.1% saponin in PBS. HCV infected cells were detected using an
anti-NS5A antibody (clone 9E10) directly conjugated with the
AlexaFluor647 fluorophore (according to manufacturer protocol;
Invitrogen, A20173). Proliferating cells were detected using Click-
iT EdU chemistry, as described above, following manufacturer
guidelines for flow cytometry analysis (Invitrogen); AlexaFluor 488
azide (1:400 dilution). Flow cytometry was performed on a BD
FACSCalibur machine with analysis done using FlowJo software
(version 8.7.1).
Human Liver Tissue Samples
Core needle liver biopsies were collected from patients at the
University of Washington All patients gave informed consent to
protocols approved by the Human Subjects Review Committee at
the University of Washington. Normal, uninfected liver tissue
(n=10) was obtained from donor livers that were considered
unacceptable for liver transplantation. These uninfected samples
were pooled to create a standard normal liver reference that was
used for all microarray experiments using patient tissue. Fibrosis
was graded by a single liver pathologist using the Batts-Ludwig
grading system [50].
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Microarray format, protocols for probe labeling, and array
hybridization are described at http://expression.microslu.
washington.edu. Briefly, a single experiment comparing two
mRNA samples was done with four replicate Human 1A (V2)
22K oligonucleotide expression arrays (Agilent Technologies)
using the dye label reverse technique. This allows for the
calculation of mean ratios between expression levels of each gene
in the analyzed sample pair, standard deviation and P values for
each experiment. Spot quantitation, normalization and applica-
tion of a platform-specific error model was performed using
Agilent’s Feature Extractor software and all data was then entered
into a custom-designed database, Expression Array Manager, and
then uploaded into Rosetta Resolver System 7.0 (Rosetta
Biosoftware, Kirkland, WA) and Spotfire Decision Suite 8.1
(Spotfire, Somerville, MA). Data normalization and the Resolver
Error Model are described on the website http://expression.
viromics.washington.edu. This website is also used to publish all
primary data in accordance with the proposed MIAME standards
[51]. Selection of genes for data analysis was based on a greater
than 95% probability of being differentially expressed (P#0.05)
and a fold change of 2 or greater. The resultant false positive
discovery rate was estimated to be less than 0.1% (Walters,
unpublished data). Ingenuity Pathway Analysis (IPA) software and
Entrez Gene (www.ncbi.nlm.nih.gov/sites) were used for gene
ontology analysis.
Quantitative RT-PCR
Quantitative real-time PCR (RT-PCR) was used to validate the
gene expression changes and measure intrahepatic HCV RNA.
Total RNA samples were treated with DNA-free DNase
Treatment and Removal Reagents (Ambion, Austin, TX). Reverse
transcription was performed using random hexamer primers and
Taqman RT reagents (Applied Biosystems, Foster City, CA). Real-
time PCR was performed using an ABI 7500 Real Time PCR
system and Taqman chemistry. Each target was run in
quadruplicate with Taqman 26PCR Universal Master Mix and
a2 0mL total reaction volume. Primer and probe sets for relative
quantification were selected from the Assays-on-Demand product
list (Applied Biosystems) including two endogenous controls,
GAPDH and 18 S ribosomal RNA. Quantification of each gene,
relative to the calibrator, was calculated by the instrument, using
the equation 2
2DDCT within the Applied Biosystems Sequence
Detections Software version 1.3. Probes used for analysis (Applied
Biosystems): Human genes: eukaryotic 18S rRNA (Catalogue
No. Hs99999901_s1); ATF3 (catalogue No. Hs00910173_ml),
MKi67 (catalogue No. Hs01032443_ml), MCM4 (catalogue
No. Hs00381539_ml), MCM6 (catalogue No. Hs00195504_ml),
TGIF1 (catalogue No. Hs00545014_ml), CAT (catalogue
No. Hs00156308_ml), SMAD7 (catalogue No. Hs00998193_ml),
GADD45A (catalogue No. Hs00169255_ml), GADD45B (cata-
logue No. Hs00169587_ml)
Primer and probe sets for absolute quantification of intrahepatic
viral load were designed based on sequences of HCV 1a armored
RNA (Ambion Diagnostics, Austin, TX) using Primer Express
(version 3). A standard curve was made from six serial dilutions of
HCV 1a armored RNA (Ambion Diagnostics) with a known viral
copy number. The PCR efficiency was determined by the slope of
the standard curve Standard curve analysis and viral load was
determined using the Applied Biosystems SDS Software 1.3
(Applied Biosystems, CA). Total RNA was DNase treated prior to
cDNA synthesis via reverse transcription and all samples were
processed with equal mass amounts of total RNA [52]. All
measurements were taken in quadruplicate with negative and non-
template controls. Primer and probe sets consisted of F: CAC
TCC CCT GTG AGG AAC TAC TG, R: GCT GCA CGA
CAC TCA TAC TAA CG, and P: 6FAM-TTC ACG CAG AAA
GC-MGBNFQ and were designed from the 59UTR using Primer
Express 3.0 (Applied Biosystems, CA). Quantification of HCV
RNA levels was performed on the same total RNA sample that
was used for the microarray experiments.
Supporting Information
Figure S1 Expression profiles of cell death-associated genes in
HCV-infected Huh-7.5 cells. Heatmap depicts 118 genes
regulated (2-fold, p value,0.05) in at least 1 experiment. Each
column represents gene expression data from an individual
experiment comparing either UV-inactivated HCV or HCV -
treated cells relative to time-matched mock-treated Huh-7.5 cells.
Genes shown in red were up-regulated, genes shown in green
down-regulated and genes in black indicate no change in
expression in HCV-infected cells relative to uninfected cells.
Found at: doi:10.1371/journal.ppat.1000269.s001 (2.36 MB TIF)
Table S1 Primary sequence name and fold-change of genes
differentially regulated during HCV infection.
Found at: doi:10.1371/journal.ppat.1000269.s002 (0.39 MB XLS)
Acknowledgments
We would like to thank Dr. Marcus Korth for his valuable scientific
comments and manuscript preparation. We would also like to thank Dr.
Anne Larson for providing patient liver biopsy specimens.
Author Contributions
Conceived and designed the experiments: KAW AJS CMR MK.
Performed the experiments: KAW AJS SLL. Analyzed the data: KAW
AJS BP. Contributed reagents/materials/analysis tools: KAW AJS DLD
BP CMR. Wrote the paper: KAW AJS CMR MK.
References
1. Alter MJH, Margolis HS, Krawczynski K, Judson F, Mares A, et al. (1992) The
natural history of community-acquired hepatitis C in the United States.
N Engl J Med 321: 1494–1500.
2. Nelson DR (2001) The immunopathogenesis of hepatitis C virus infection. Clin
Liver Dis 5: 931–953.
3. Mengshol JA, Golden-Mason L, Rosen HR (2007) Mechanisms of
Disease: HCV-induced liver injury. Nat Clin Pract Gastroenterol Hepatol 4:
622–634.
4. Abel M, Sene D, Pol S, Bourliere M, Poynard T, et al. (2006) Intrahepatic virus-
specific IL-10-producing CD8 T cells prevent liver damage during chronic
hepatitis C virus infection. Hepatology 44: 1607–1616.
5. Walters KA, Joyce MA, Thompson JC, Smith MW, Yeh MM, et al. (2006)
Host-specific response to HCV infection in the chimeric SCID-beige/Alb-uPA
mouse model: role of the innate antiviral immune response. PLoS Pathog 2:
e259. doi:10.1371/journal.ppat.0020059.
6. Wakita T, Pietschmann T, Kato T, Date T, Miyamoto M, et al. (2005)
Production of infectious hepatitis C virus in tissue culture from a cloned viral
genome. Nat Med 11: 791–796.
7. Lindenbach BD, Evans MJ, Syder AJ, Wolk B, Tellinghuisen TL, et al. (2005)
Complete replication of hepatitis C virus in cell culture. Science 309: 623–626.
8. Lindenbach BD, Meuleman P, Ploss A, Vanwolleghem T, Syder AJ, et al. (2006)
Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in
vitro. Proc Natl Acad Sci U S A 103: 3805–3809.
9. Zhong J, Gastaminza P, Cheng G, Kapadia S, Kato T, et al. (2005) Robust
hepatitis C virus infection in vitro. Proc Natl Acad Sci U S A 102: 9294–9299.
10. Bates S, Vousden KH (1996) p53 in signaling checkpoint arrest or apoptosis.
Curr Opin Genet Dev 6: 12–18.
11. Spurgers KB, Gold DL, Coombes KR, Bohnenstiehl NL, Mullins B, et al. (2006)
Identification of cell cycle regulatory genes as principal targets of p53-mediated
transcriptional repression. J Biol Chem 281: 25134–25142.
Cell Cycle Perturbation in HCV-Mediated Apoptosis
PLoS Pathogens | www.plospathogens.org 12 January 2009 | Volume 5 | Issue 1 | e100026912. Robinson M, Jiang P, Cui J, Li J, Wang Y, et al. (2003) Global genechip profiling
to identify genes responsive to p53-induced growth arrest and apoptosis in
human lung carcinoma cells. Cancer Biol Ther 2: 406–415.
13. Lee KY, Bae SC (2002) TGF-beta-dependent cell growth arrest and apoptosis.
J Biochem Mol Biol 35: 47–53.
14. Schuster N, Krieglstein K (2002) Mechanisms of TGF-beta-mediated apoptosis.
Cell Tissue Res 307: 1–14.
15. Dupont S, Zacchigna L, Adorno M, Soligo S, Volpin D, et al. (2004)
Convergence of p53 and TGF-beta signaling networks. Cancer Lett 213:
129–138.
16. Geiss GK, An MC, Bumgarner RE, Hammersmark E, Cunningham D, et al.
(2001) Global impact of influenza virus on cellular pathways is mediated by both
replication-dependent and -independent events. J Virol 75: 4321–4331.
17. Wieland S, Thimme R, Purcell RH, Chisari FV (2004) Genomic analysis of the
host response to hepatitis B virus infection. Proc Natl Acad Sci U S A 101:
6669–6674.
18. Doughty AL, Spencer JD, Cossart YE, McCaughan GW (1998) Cholestatic
hepatitis after liver transplantation is associated with persistently high serum
hepatitis C virus RNA levels. Liver Transpl Surg 4: 15–21.
19. Pelletier SJ, Raymond DP, Crabtree TD, Berg CL, Iezzoni JC, et al. (2000)
Hepatitis C-induced hepatic allograft injury is associated with a pretransplan-
tation elevated viral replication rate. Hepatology 32: 418–426.
20. Di MV, Saurini F, Samuel D, Gigou M, Dussaix E, Reynes M, et al. (1997)
Long-term longitudinal study of intrahepatic hepatitis C virus replication after
liver transplantation. Hepatology 26: 1343–1350.
21. Pal S, Shuhart MC, Thomassen L, Emerson SS, Su T, et al. (2006) Intrahepatic
hepatitis C virus replication correlates with chronic hepatitis C disease severity in
vivo. J Virol 80: 2280–2290.
22. Marshall A, Rushbrook S, Morris LS, Scott IS, Vowler SL, et al. (2005)
Hepatocyte expression of minichromosome maintenance protein-2 predicts
fibrosis progression after transplantation for chronic hepatitis C virus: a pilot
study. Liver Transpl 11: 427–433.
23. Marshall A, Rushbrook S, Davies SE, Morris LS, Scott IS, et al. (2005) Relation
between hepatocyte G1 arrest, impaired hepatic regeneration, and fibrosis in
chronic hepatitis C virus infection. Gastroenterology 128: 33–42.
24. Bostik P, Dodd GL, Villinger F, Mayne AE, Ansari AA (2004) Perturbation of
the polo-like kinase pathway in CD4+ T cells is characteristic of pathogenic
simian immunodeficiency virus infection. J Virol 78: 1464–1472.
25. Paiardini M, Cervasi B, Dunham R, Sumpter B, Radziewicz H, et al. (2004)
Cell-cycle perturbation in the immunopathogenesis of AIDS. Immunol Res 29:
253–268.
26. Paiardini M, Cervasi B, Sumpter B, McClure HM, Sodora DL, et al. (2006)
Perturbations of cell cycle control in T cells contribute to the different outcomes
of simian immunodeficiency virus infection in rhesus macaques and sooty
mangabeys. J Virol 80: 634–642.
27. Park US, Park SK, Lee YI, Park JG, Lee YI (2000) Hepatitis B virus-X protein
upregulates the expression of p21waf1/cip1 and prolongs G1–.S transition via
a p53-independent pathway in human hepatoma cells. Oncogene 19:
3384–3394.
28. Shostak LD, Ludlow J, Fisk J, Pursell S, Rimel BJ, et al. (1999) Roles of p53 and
caspases in the induction of cell cycle arrest and apoptosis by HIV-1 vpr. Exp
Cell Res 251: 156–165.
29. Nguyen H, Mudryj M, Guadalupe M, Dandekar S (2003) Hepatitis C virus core
protein expression leads to biphasic regulation of the p21 cdk inhibitor and
modulation of hepatocyte cell cycle. Virology %20 312: 245–253.
30. Ohkawa K, Ishida H, Nakanishi F, Hosui A, Ueda K, et al. (2004) Hepatitis C
virus core functions as a suppressor of cyclin-dependent kinase-activating kinase
and impairs cell cycle progression. J Biol Chem 279: 11719–11726.
31. Yao ZQ, Eisen-Vandervelde A, Ray S, Hahn YS (2003) HCV core/gC1qR
interaction arrests T cell cycle progression through stabilization of the cell cycle
inhibitor p27Kip1. Virology 314: 271–282.
32. Yang XJ, Liu J, Ye L, Liao QJ, Wu JG, et al. (2006) HCV NS2 protein inhibits
cell proliferation and induces cell cycle arrest in the S-phase in mammalian cells
through down-regulation of cyclin A expression. Virus Res 121: 134–143.
33. Naka K, Dansako H, Kobayashi N, Ikeda M, Kato N (2006) Hepatitis C virus
NS5B delays cell cycle progression by inducing interferon-beta via Toll-like
receptor 3 signaling pathway without replicating viral genomes. Virology 346:
348–362.
34. Baek KH, Park HY, Kang CM, Kim SJ, Jeong SJ, et al. (2006) Overexpression
of hepatitis C virus NS5A protein induces chromosome instability via mitotic cell
cycle perturbation. J Mol Biol 359: 22–34.
35. Sainz B Jr, Chisari FV (2006) Production of infectious hepatitis C virus by well-
differentiated, growth-arrested human hepatoma-derived cells. J Virol 80:
10253–10257.
36. Nelson HB, Tang H (2006) Effect of cell growth on hepatitis C virus (HCV)
replication and a mechanism of cell confluence-based inhibition of HCV RNA
and protein expression. J Virol 80: 1181–1190.
37. Okuda M, Li K, Beard MR, Showalter LA, Scholle F, et al. (2002)
Mitochondrial injury, oxidative stress, and antioxidant gene expression are
induced by hepatitis C virus core protein. Gastroenterology 122: 366–375.
38. Machida K, Cheng KT, Lai CK, Jeng KS, Sung VM, et al. (2006) Hepatitis C
virus triggers mitochondrial permeability transition with production of reactive
oxygen species, leading to DNA damage and STAT3 activation. J Virol 80:
7199–7207.
39. Korenaga M, Wang T, Li Y, Showalter LA, Chan T, et al. (2005) Hepatitis C
virus core protein inhibits mitochondrial electron transport and increases
reactive oxygen species (ROS) production. J Biol Chem 280: 37481–37488.
40. Tang W, Lazaro CA, Campbell JS, Parks WT, Katze MG, et al. (2007)
Responses of nontransformed human hepatocytes to conditional expression of
full-length hepatitis C virus open reading frame. Am J Pathol 171: 1831–1846.
41. Gewaltig J, Mangasser-Stephan K, Gartung C, Biesterfeld S, Gressner AM
(2002) Association of polymorphisms of the transforming growth factor-beta1
gene with the rate of progression of HCV-induced liver fibrosis. Clin Chim Acta
316: 83–94.
42. Calabrese F, Valente M, Giacometti C, Pettenazzo E, Benvegnu L, et al. (2003)
Parenchymal transforming growth factor beta-1: its type II receptor and Smad
signaling pathway correlate with inflammation and fibrosis in chronic liver
disease of viral etiology. J Gastroenterol Hepatol 18: 1302–1308.
43. Nelson DR, Gonzalez-Peralta RP, Qian K, Xu Y, Marousis CG, et al. (1997)
Transforming growth factor-beta 1 in chronic hepatitis C. J Viral Hepat 4:
29–35.
44. Smith MW, Walters K-A, Korth MJ, Fitzgibbon M, Proll SC, et al. (2006) Gene
expression patterns that correlate with hepatitis C and early progression to
fibrosis in liver transplant recipients. Gastroenterol 130: 179–187.
45. Teixeira R, Marcos LA, Friedman SL (2007) Immunopathogenesis of hepatitis
C virus infection and hepatic fibrosis: New insights into antifibrotic therapy in
chronic hepatitis C. Hepatol Res 37: 579–595.
46. Sekine-Osajima Y, Sakamoto N, Mishima K, Nakagawa M, Itsui Y, et al. (2008)
Development of plaque assays for hepatitis C virus-JFH1 strain and isolation of
mutants with enhanced cytopathogenicity and replication capacity. Virology
371: 71–85.
47. Deng L, Adachi T, Kitayama K, Bungyoku Y, Kitazawa S, et al. (2008)
Hepatitis C virus infection induces apoptosis through a Bax-triggered,
mitochondrion-mediated, caspase 3-dependent pathway. J Virol 82:
10375–10385.
48. Zhu H, Dong H, Eksioglu E, Hemming A, Cao M, et al. (2007) Hepatitis C virus
triggers apoptosis of a newly developed hepatoma cell line through antiviral
defense system. Gastroenterology 133: 1649–1659.
49. Sarfraz S, Hamid S, Siddiqui A, Hussain S, Pervez S, et al. (2008) Altered
expression of cell cycle and apoptotic proteins in chronic hepatitis C virus
infection. BMC Microbiol 8: 133.
50. Batts KP, Ludwig J (1995) Chronic hepatitis. An update on terminology and
reporting. Am J Surg Pathol 19: 1409–1417.
51. Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, et al. (2001)
Minimum information about a microarray experiment (MIAME) toward
standards for microarray data. Nature Genet 29: 365–371.
52. Mayerat C, Burgisser P, Lavanchy D, Mantegani A, Frei PC (1996) Comparison
of a competitive combined reverse transcription-PCR assay with a branched-
DNA assay for hepatitis C virus RNA quantitation. J Clin Microbiol 34:
2702–2706.
Cell Cycle Perturbation in HCV-Mediated Apoptosis
PLoS Pathogens | www.plospathogens.org 13 January 2009 | Volume 5 | Issue 1 | e1000269